ABOUT USBuilding the Next Great
Orthopaedic Company
Medel is a commercial-stage medical device company pioneering bio-electric joint preservation technology. With 20+ years of clinical proof, we are transforming the treatment of osteoarthritis worldwide.
OUR MISSIONFilling the Treatment Gap for 600 Million Patients
For decades, 66-70% of osteoarthritis patients have been trapped between conservative care that only masks symptoms and joint replacement surgery they are too young or not severe enough to receive. There has been literally nothing for them.
Medel exists to change that. Our IMPLESO technology is the world's first and only wireless bio-electric therapeutic implant for joint preservation — filling a $5-7 billion treatment gap where no disease-modifying solution has ever existed.
"We didn't just repair a joint. We restored a life."
OUR STORYYears of Clinical Innovation
Medel's journey began with a fundamental insight: bone is electrical. It generates its own healing signals. Professor Mikhail Morgunov, our founder, spent years developing the proprietary electret technology that would become IMPLESO, the first device to harness the body's own bio-electric healing mechanisms.
Today, Medel is one of the leading breakthrough orthopaedic medtech companies, working on expanding regulatory approval worldwide. We have treated thousands of patients across four clinical indications, and we won't stop until we are the standard of care for osteoarthritis for a wide range of orthopaedic applications.
1000s
Patients Treated Worldwide
100s
Patients in Longitudinal Clinical Studies
0
Device-Related Serious Adverse Events in Clinical Studies
What Drives Us
🔬
Scientific Rigor
Every claim has a citation. Every decision is data-driven. We lead with published, peer-reviewed evidence and validated clinical outcomes.
💓
Patient Dignity
We exist because millions of people were told to live in pain. We treat patients as people, not market segments. Clinical empathy guides every decision we make.
🛡️
Operational Excellence
ISO 13485 manufacturing. Global regulatory compliance. Every process built to the standard expected by tier-one strategic acquirers and institutional investors.
🌍
Global Vision
600 million patients worldwide need this technology. Our patent portfolio spans 12 countries, and our commercial strategy targets multiple continents simultaneously.
Ready to Learn More?
Whether you are a surgeon, investor, distributor, or strategic partner — we would welcome the conversation.